Latest News
Trump's relationship with cryptocurrency is undergoing a strategic shift. Through his family-backed project, World Free Finance (WLFI), his team is pushing for the regulation of cryptocurrencies and the legalization of stablecoins, highlighting the growing importance of digital assets in high-level strategy. Against this backdrop, the market is shifting towards mature assets with clearly defined use [...]
Via Visibility · January 1, 2026
After more than doubling the market's return in 2025, the country's most valuable company should keep rolling in the year ahead.
Via The Motley Fool · January 2, 2026
This ETF could produce robust total returns in 2026 and beyond.
Via The Motley Fool · January 2, 2026
January is when small credit card missteps quietly turn into interest charges, missed rewards, and avoidable score damage.
Via The Motley Fool · January 2, 2026
Gulfport Energy Corp (NYSE:GPOR) Emerges as a High-Growth Momentum Candidate via Minervini's SEPA Strategychartmill.com
Via Chartmill · January 2, 2026
BIRKENSTOCK HOLDING PLC (NYSE:BIRK): A Prime Example of Affordable Growthchartmill.com
Via Chartmill · January 2, 2026
HCI Group Inc (NYSE:HCI) Clears Minervini and High Growth Momentum Screenchartmill.com
Via Chartmill · January 2, 2026
Thiel made some significant moves during the third quarter.
Via The Motley Fool · January 2, 2026
Gold has been on an epic run.
Via The Motley Fool · January 2, 2026
Oracle was at the center of all things artificial intelligence (AI) in 2025, and therefore at the center of the investing world.
Via The Motley Fool · January 2, 2026
Dividend ETFs may be out of favor, but passive income is always in style.
Via The Motley Fool · January 2, 2026
BitFarms agreed to sell its 70 MW site in Paraguay to a crypto infrastructure fund for $30 million as part of its plans to fully exit LatAm.
Via Stocktwits · January 2, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · January 2, 2026
Spot gold prices were up nearly 2% at the time of writing, while spot silver prices gained over 4%.
Via Stocktwits · January 2, 2026
The U.S. health regulatory agency, the FDA, rejected Outlook Therapeutics’ application for approval of its drug Lytenava, which is intended to treat wet AMD.
Via Stocktwits · January 2, 2026
025 was a bad one in many ways, except for investment.
Via Talk Markets · January 2, 2026
The stock's decline can be explained, and doesn't diminish the company's long-term potential.
Via The Motley Fool · January 2, 2026
Both can be great portfolio anchors.
Via The Motley Fool · January 2, 2026
Via MarketBeat · January 2, 2026
Some of these REITs sport dividend yields that top 6%.
Via The Motley Fool · January 2, 2026
With the right strategy, you can make the most of your workplace plan.
Via The Motley Fool · January 2, 2026
On Wednesday, the AI solutions provider said it has closed a $250 million cash deal, expanding its footprint in mission-critical generative artificial intelligence across government and regulated sectors.
Via Stocktwits · January 2, 2026
Costco stock is underperforming the market. Is it time to buy on the dip?
Via The Motley Fool · January 2, 2026
Palantir stock can take investors for a roller-coaster ride. Two questions can help traders identify whether a stock is worth keeping.
Via Investor's Business Daily · January 2, 2026